Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-12-048261)

Filing Details

Accession Number:: 0001209191-12-048261
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-10-03 20:10:12
Reporting Period:: 2012-10-01

Filing Date:: 2012-10-03
Accepted Time:: 2012-10-03 19:10:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1340652	Chemocentryx Inc.	CCXI	Pharmaceutical Preparations (2834)	943254365

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1226064	M Susan Kanaya	C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043	Svp, Finance, Cfo And Sec.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-10-01	3,971	$2.00	3,971	No	4	M	Direct
Common Stock	Disposition	2012-10-01	3,971	$11.89	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2012-10-01	3,971	$0.00	3,971	$2.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
203,529		2016-02-09	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Reflects the weighted average sale price of the shares sold. 3,933 shares were sold at $11.89 per share and 38 shares were sold at $11.90 per share.
As of October 1, 2012 and prior to this transaction, the option fully vested.
Not applicable.